Cargando…
Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression
Hepatitis B x protein (HBx) affects cellular protein expression and participates in the tumorigenesis and progression of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Metabolic reprogramming contributed to the HCC development, but its role in HBV-related HCC remains largely unclear...
Autores principales: | Yan, Yongcong, Huang, Pinbo, Mao, Kai, He, Chuanchao, Xu, Qiaodong, Zhang, Mengyu, Liu, Haohan, Zhou, Zhenyu, Zhou, Qiming, Zhou, Qianlei, Ou, Bing, Liu, Qinghua, Lin, Jianhong, Chen, Ruibin, Wang, Jie, Zhang, Jianlong, Xiao, Zhiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790756/ https://www.ncbi.nlm.nih.gov/pubmed/33051595 http://dx.doi.org/10.1038/s41388-020-01498-3 |
Ejemplares similares
-
Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study
por: Xiao, Zhiyu, et al.
Publicado: (2019) -
PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK
por: Zhou, Qiming, et al.
Publicado: (2020) -
A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer
por: Yan, Yongcong, et al.
Publicado: (2020) -
Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis
por: Yan, Yongcong, et al.
Publicado: (2019) -
INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma
por: Zhou, Qianlei, et al.
Publicado: (2022)